Synthesis 2015; 47(22): 3467-3472
DOI: 10.1055/s-0034-1378746
paper
© Georg Thieme Verlag Stuttgart · New York

Scalable and Straightforward Synthesis of a 2-Alkyl-7-Arylbenzo­thiophene as a GPR52 Agonist via a Hemithioindigo Derivative

Naohiro Fukuda*
Chemical Development Laboratories, Takeda Pharmaceutical Company Limited, Yodogawa-ku, Osaka 532-8686, Japan   eMail: naohiro.fukuda@takeda.com
,
Tomomi Ikemoto
Chemical Development Laboratories, Takeda Pharmaceutical Company Limited, Yodogawa-ku, Osaka 532-8686, Japan   eMail: naohiro.fukuda@takeda.com
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 01. Juni 2015

Accepted after revision: 29. Juni 2015

Publikationsdatum:
11. August 2015 (online)


Abstract

A simple and efficient procedure has been developed for the synthesis of the GPR52 agonist N-(2-amino-2-oxoethyl)-3-{4-fluoro-2-[3-(trifluoromethyl)benzyl]-1-benzothien-7-yl}benzamide. The benzo­thiophene unit was directly constructed by reduction of a hemithioindigo derivative prepared by an intramolecular Friedel–Crafts cyclization of (phenylsulfanyl)acetic acid, followed by dehydrative benzylidene formation.

Supporting Information

 
  • References

  • 1 Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH. Q, George SR, O’Dowd BF. Mol. Brain Res. 1999; 64: 193
    • 2a Setoh M, Ishii N, Kono M, Miyanohana Y, Shiraishi E, Harasawa T, Ota H, Odani T, Kanzaki N, Aoyama K, Hamada T, Kori M. J. Med. Chem. 2014; 57: 5226
    • 2b Komatsu H, Maruyama M, Yao S, Shinohara T, Sakuma K, Imaichi S, Chikatsu T, Kuniyeda K, Sui FK, Peng LS, Zhuo K, Mun LS, Han TM, Matsumoto Y, Hashimoto T, Miyajima N, Ito Y, Ogi K, Habata Y, Mori M. PLoS One 2014; 9: e90134
    • 2c Setoh M, Kobayashi T, Tanaka T, Baba A. WO 2009107391, 2009
    • 3a Horton DA, Bourne GT, Smythe ML. Chem. Rev. 2003; 103: 893
    • 3b Berrade L, Aisa B, Ramirez MJ, Galiano S, Guccione S, Moltzau LR, Levy FO, Nicoletti F, Battaglia G, Molinaro G, Aldana I, Monge A, Perez-Silanes S. J. Med. Chem. 2011; 54: 3086
    • 3c Qin Z, Kastrati I, Chandrasena RE. P, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GR. J. J. Med. Chem. 2007; 50: 2682
    • 3d Flynn BL, Hamel E, Jung MK. J. Med. Chem. 2002; 45: 2670
    • 3e Hsiao C.-N, Kolasa T. Tetrahedron Lett. 1992; 33: 2629
    • 4a Fouad I, Mechbal Z, Chane-Ching KI, Adenier A, Maurel F, Aaron J.-J, Vodicka P, Cernovska K, Kozmik V, Svoboda J. J. Mater. Chem. 2004; 14: 1711
    • 4b Jung KH, Kim KH, Lee DH, Jung DS, Park CE, Choi DH. Org. Electron. 2010; 11: 1584
    • 4c Pu S, Li M, Fan C, Liu G, Shen L. J. Mol. Struct. 2009; 919: 100
    • 4d Um M.-C, Kwak J, Hong J.-P, Kang J, Yoon DY, Lee SH, Lee C, Hong J.-I. J. Mater. Chem. 2008; 18: 4698
    • 5a Gabriele B, Mancuso R, Lupinacci E, Veltri L, Salerno G, Carfagna C. J. Org. Chem. 2011; 76: 8277
    • 5b Duan Z, Ranjit S, Liu X. Org. Lett. 2010; 12: 2430
    • 5c Wang Z, Geng W, Wang H, Zhang S, Zhang W.-X, Xi Z. Tetrahedron Lett. 2011; 52: 6997
    • 5d Benati L, Montevecchi PC, Spagnolo P. J. Chem. Soc., Perkin Trans. 1 1992; 1659
    • 5e Hari DP, Hering T, König B. Org. Lett. 2012; 14: 5334
    • 5f Clark PD, Kirk A, Yee JG. K. J. Org. Chem. 1995; 60: 1936
    • 5g Lin C.-H, Chen C.-C, Wu M.-J. Chem. Eur. J. 2013; 19: 2578
    • 6a Capozzi G, Melloni G, Modena G. J. Chem. Soc. C 1970; 2621
    • 6b Jones CD, Jevnikar MG, Pike AJ, Peters MK, Black LJ, Thompson AR, Falcone JF, Clemens JA. J. Med. Chem. 1984; 27: 1057
    • 6c Pinney KG, Bounds AD, Dingeman KM, Mocharla VP, Pettit GR, Bai R, Hamel E. Bioorg. Med. Chem. Lett. 1999; 9: 1081
    • 7a Sun L.-L, Deng C.-L, Tang R.-Y, Zhang X.-G. J. Org. Chem. 2011; 76: 7546
    • 7b Kashiki T, Shinamura S, Kohara M, Miyazaki E, Takimiya K, Ikeda M, Kuwabara H. Org. Lett. 2009; 11: 2473
    • 8a Ebata H, Miyazaki E, Yamamoto T, Takimiya K. Org. Lett. 2007; 9: 4499
    • 8b Zhou Y, Liu W.-J, Ma Y, Wang H, Qi L, Cao Y, Wang J, Pei J. J. Am. Chem. Soc. 2007; 129: 12386
    • 8c Hessian KO, Flynn BL. Org. Lett. 2003; 5: 4377
    • 8d Larock RC, Yue D. Tetrahedron Lett. 2001; 42: 6011
    • 8e Flynn BL, Verdier-Pinard P, Hamel E. Org. Lett. 2001; 5: 651
    • 9a Kuhn M, Falk FC, Paradies J. Org. Lett. 2011; 13: 4100
    • 9b Lyons TW, Sanford MS. Chem. Rev. 2010; 110: 1147
    • 9c Bryan CS, Braunger JA, Lautens M. Angew. Chem. Int. Ed. 2009; 48: 7064
    • 10a Yu H, Zhang M, Li Y. J. Org. Chem. 2013; 78: 8898
    • 10b Newman SG, Aureggi V, Bryan CS, Lautens M. Chem. Commun. 2009; 5236
    • 10c Lu W.-D, Wu M.-J. Tetrahedron 2007; 63: 356
    • 10d Kunz T, Knochel P. Angew. Chem. Int. Ed. 2012; 51: 1958
  • 11 Liu K, Jia F, Xi H, Li Y, Zheng X, Guo Q, Shen B, Li Z. Org. Lett. 2013; 15: 2026
  • 12 Nakamura I, Sato T, Yamamoto Y. Angew. Chem. Int. Ed. 2006; 45: 4473
  • 13 Godoi B, Schumacher RF, Zeni G. Chem. Rev. 2011; 111: 2937
  • 14 Inamoto K, Arai Y, Hiroya K, Doi T. Chem. Commun. 2008; 5529
    • 15a Duez S, Steib AK, Knochel P. Org. Lett. 2012; 14: 1951
    • 15b Shrestha S, Hwang SY, Lee K.-H, Cho H. Bull. Korean Chem. Soc. 2005; 26: 1138
    • 15c Lapointe D, Fagnou K. Org. Lett. 2009; 11: 4160
    • 15d Imamura M, Nakanishi K, Suzuki T, Ikegai K, Shiraki R, Ogiyama T, Murakami T, Kurosaki E, Noda A, Kobayashi Y, Yokota M, Koide T, Kosakai K, Ohkura Y, Takeuchi M, Tomiyama H, Ohta M. Bioorg. Med. Chem. 2012; 20: 3263
    • 15e Robbins DW, Hartwig JF. Angew. Chem. Int. Ed. 2013; 52: 933
    • 16a Anderson NG. Practical Process Research and Development: A Guide for Organic Chemists . 2nd ed. Elsevier Academic Press; Amsterdam: 2012
    • 16b Repič O. Principles of Process Research and Chemical Development in the Pharmaceutical Industry. Wiley; New York: 1998
  • 17 Varedian M, Langer V, Bergquist J, Gogoll A. Tetrahedron Lett. 2008; 49: 6033
  • 18 Kurosawa K, Morita Y. Bull. Chem. Soc. Jpn. 1981; 54: 635
    • 19a Burger U, Bringhen AO. Helv. Chim. Acta 1989; 72: 93
    • 19b Sainsbury M, Webb B, Schinazi R. J. Chem. Soc., Perkin Trans. 1 1975; 289
  • 20 The selectivity was determined by 1H NMR. Ethyl [(2-Bromo-5-fluorophenyl)sulfanyl]acetate (12) 1H NMR (600 MHz, CDCl3): δ = 1.27 (t, J = 7.2 Hz, 3 H), 3.68 (s, 2 H), 4.21 (q, J = 7.2 Hz, 2 H), 6.79 (t, J = 8.3 Hz, 1 H), 7.09 (dd, J = 9.3, 2.8 Hz, 1 H), 7.49 (t, J = 7.5 Hz, 1 H); 13C NMR (151 MHz, CDCl3): δ = 14.1, 35.4, 61.9, 114.4 (d, J = 22.3 Hz), 115.6 (d, J = 25.6 Hz), 117.4 (d, J = 3.3 Hz), 134.0 (d, J = 8.2 Hz), 139.0 (d, J = 8.2 Hz), 162.1 (d, J = 249.0 Hz), 168.6. Ethyl [(4-Bromo-3-fluorophenyl)sulfanyl]acetate (Regioisomer of 12) 1H NMR (600 MHz, CDCl3): δ = 1.25 (t, J = 7.1 Hz, 3 H), 3.64 (s, 2 H), 4.19 (q, J = 7.3 Hz, 2 H), 7.05 (ddd, J = 8.4, 2.2, 0.8 Hz, 1 H), 7.17 (dd, J = 9.0, 2.1 Hz, 1 H), 7.46 (dd, J = 8.2, 7.3 Hz, 1 H); 13C NMR (151 MHz, CDCl3): δ = 14.1, 36.3, 61.8, 107.3 (d, J = 21.3 Hz), 117.3 (d, J = 24.5 Hz), 126.1 (d, J = 3.3 Hz), 133.7, 136.9 (d, J = 7.1 Hz), 159.0 (d, J = 250.1 Hz), 169.1.
  • 21 Eggers K, Fyles TM, Montoya-Pelaez PJ. J. Org. Chem. 2001; 66: 2966
    • 22a Fukuda N, Kajiwara T, Katou T, Majima K, Ikemoto T. Synlett 2013; 24: 1438
    • 22b Fukuda N, Izumi M, Ikemoto T. Tetrahedron Lett. 2015; 56: 3905
  • 23 Zhang TY. Handbook of Green Chemistry and Technology . Clark J, Macquarrie D. Blackwell Science; Oxford: 2002: 312
  • 24 Rueping M, Vila C, Szadkowska A, Koenigs RM, Fronert J. ACS Catal. 2012; 2: 2810